Cingulate Inc. (CING) Financials
CING Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 5.9 million | 6.0 million |
| 2023-06-30 | 5.2 million | 11.3 million |
| 2023-03-31 | 7.2 million | 7.1 million |
| 2022-12-31 | 11.4 million | 7.5 million |
CING Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -4.3 million | 236251 |
| 2023-06-30 | -4.6 million | 217376 |
| 2023-03-31 | -3.6 million | 204479 |
| 2022-12-31 | -4.3 million | 206436 |
CING Net Income
No data available :(
CING Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 2.0 million | - | 604148 |
| 2023-06-30 | 349831 | - | 346983 |
| 2023-03-31 | 1.7 million | - | 783128 |
| 2022-12-31 | 5.4 million | - | 526288 |
CING Shares Outstanding
CING Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 3.9 million | 1.8 million | - |
| 2023-06-30 | 1 | 4.5 million | 1.9 million | - |
| 2023-03-31 | 37135 | 2.1 million | 1.7 million | - |
| 2022-12-31 | 143020 | 1.9 million | 2.5 million | - |
CING Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 5.7 million |
| 2023-06-30 | - | 6.4 billion |
| 2023-03-31 | 3.8 billion | 2128 |
| 2022-12-31 | - | 149878 |
CING
Price: $1.12
52 week price:
Earnings Per Share: -26.00 USD
P/E Ratio: -0.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 16900
Market Capitalization: 4.6 million